MindWalk Holdings (HYFT) Divestments (2024 - 2026)
MindWalk Holdings (HYFT) posted quarterly Divestments of -$72778.5 for Q3 2025, up 47.27% year-over-year from -$49417.4 in Q3 2024, and down 78.56% quarter-over-quarter from -$40758.3 in Q2 2025.
MindWalk Holdings (HYFT) Divestments (2024 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Divestments for 2 consecutive years, with -$72778.5 the latest figure, recorded in Q3 2025.
- In Q3 2025, Divestments rose 47.27% year-over-year to -$72778.5; the TTM figure through Apr 2026 stood at -$72778.5 (up 67.75% YoY), while the FY2026 annual figure was -$72950.6, up 67.33% from the prior year.
- Divestments fell to -$72778.5 in Q3 2025 per HYFT's latest filing, from -$40758.3 in the prior quarter.
- Across five years, Divestments topped out at -$40758.3 in Q2 2025 and bottomed at -$138029.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 9.82 Mn |
| Jan 31, 2026 | -9.29 Mn |
| Oct 31, 2025 | -53,345.05 |
| Jul 31, 2025 | -72,778.53 |
| Apr 30, 2025 | -40,758.26 |
| Oct 31, 2024 | -46,866.48 |
| Jul 31, 2024 | -138,028.96 |